-
Company
-
Production
-
R&D
-
Product & Service
-
Investor Relations
With continuous research and development,
we focus on the development and production
of high value-added products.
We are moving forward to become a global leader
in probiotics & pharmaceuticals with world-class
technology and continuous and innovative research & development.
Chong Kun Dang Central Research Institute,
established in 1972 for the first time in
Korean Pharmaceutical Industry
Main Research Areas
Our Central Research Institute is always trying to become leader in biotechnology development
01
-
01 Probiotics Research
Production of probiotics from the spawn separation, optimization of mass production, functional strain and finished product development specific to CKD BiO
Through research on all fronts, we are leading the development of next generation probiotics through microbiome research. 02
-
02 Fermentation Research
Using CKD BiO’s accumulated fermentation technology,
we are conducting research on the discovery of useful
product-generating microorganisms, strain improvement,
optimization of fermentation process and bioconversion of target products. 03
-
03 Tablet Separation & Synthetic Research
We are developing useful materials production technology through
recovery of useful materials from microbial culture, semi-synthesis
and chemical synthesis. To make this happen, we are conducting
research on optimizing synthesis and purification processes,
identifying spectral structures, developing analytical methods,
and separating flexible materials.
Global Competitive Fermented
Raw Materials Pharmaceuticals
Provides differentiated services
Probiotics fermented raw
medicine it’s produced.